Company intelligence / Profile preview

Smith Biotech

Ownership: Private
Development stage: Other

Overview

Smith Biotech is a biotechnology company focused on the development of novel therapeutic solutions, primarily in the areas of oncology and infectious diseases. The company leverages its expertise in small molecule and peptide chemistry to identify and optimize drug candidates for unmet medical needs. While currently in the pre-clinical stage, Smith Biotech aims to advance its internal pipeline through rigorous research and strategic collaborations. The company is positioned as an early-stage innovator within the life sciences ecosystem, seeking to translate scientific discoveries into viable clinical programs.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Smith Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smith Biotech.

Explore the full profile